Article
Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis.
The pharmacogenomics journal - 1 Jan 2018
Sode J, Vogel U, Bank S, Andersen P S, Hetland M L, Locht H, Heegaard N H H, Andersen V
Abstract excerpt
Several genetic variants in Toll-like receptor (TLR) and nuclear factor (NF)-κB signalling pathways have been reported associated with responsiveness to tumour necrosis factor inhibitor (anti-TNF) treatment in rheumatoid arthritis (RA). The present study was undertaken to replicate these findings. In a retrospective case-case study including 1007 Danish anti-TNF-treated RA patients, we genotyped 7 previously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
